1. Home
  2. ONMD vs ELEV Comparison

ONMD vs ELEV Comparison

Compare ONMD & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONMD
  • ELEV
  • Stock Information
  • Founded
  • ONMD 2006
  • ELEV 2019
  • Country
  • ONMD United States
  • ELEV United States
  • Employees
  • ONMD N/A
  • ELEV N/A
  • Industry
  • ONMD
  • ELEV Biotechnology: Pharmaceutical Preparations
  • Sector
  • ONMD
  • ELEV Health Care
  • Exchange
  • ONMD Nasdaq
  • ELEV Nasdaq
  • Market Cap
  • ONMD 32.5M
  • ELEV 37.6M
  • IPO Year
  • ONMD N/A
  • ELEV 2021
  • Fundamental
  • Price
  • ONMD $0.99
  • ELEV $0.61
  • Analyst Decision
  • ONMD
  • ELEV Buy
  • Analyst Count
  • ONMD 0
  • ELEV 6
  • Target Price
  • ONMD N/A
  • ELEV $7.20
  • AVG Volume (30 Days)
  • ONMD 90.9K
  • ELEV 1.3M
  • Earning Date
  • ONMD 12-17-2024
  • ELEV 03-05-2025
  • Dividend Yield
  • ONMD N/A
  • ELEV N/A
  • EPS Growth
  • ONMD N/A
  • ELEV N/A
  • EPS
  • ONMD 0.01
  • ELEV N/A
  • Revenue
  • ONMD $957,651.00
  • ELEV N/A
  • Revenue This Year
  • ONMD N/A
  • ELEV N/A
  • Revenue Next Year
  • ONMD N/A
  • ELEV N/A
  • P/E Ratio
  • ONMD $120.13
  • ELEV N/A
  • Revenue Growth
  • ONMD 1.36
  • ELEV N/A
  • 52 Week Low
  • ONMD $0.46
  • ELEV $0.50
  • 52 Week High
  • ONMD $3.37
  • ELEV $5.83
  • Technical
  • Relative Strength Index (RSI)
  • ONMD 45.51
  • ELEV 43.44
  • Support Level
  • ONMD $0.90
  • ELEV $0.64
  • Resistance Level
  • ONMD $1.06
  • ELEV $0.72
  • Average True Range (ATR)
  • ONMD 0.07
  • ELEV 0.05
  • MACD
  • ONMD 0.00
  • ELEV -0.00
  • Stochastic Oscillator
  • ONMD 60.00
  • ELEV 18.41

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real-World Data or iRWDTM. OneMedNet's innovative solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and the associated contextual patient record.

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

Share on Social Networks: